about
Expression and function of junctional adhesion molecule-C in myelinated peripheral nervesComplement activation in multiple sclerosis plaques: an immunohistochemical analysis.Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space.Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosisComplement is activated in progressive multiple sclerosis cortical grey matter lesions.New hyperekplexia mutations provide insight into glycine receptor assembly, trafficking, and activation mechanisms.Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus.NPY mediates basal and seizure-induced proliferation in the subcallosal zone.A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look.Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.GLRB is the third major gene of effect in hyperekplexia.NPY augments the proliferative effect of FGF2 and increases the expression of FGFR1 on nestin positive postnatal hippocampal precursor cells, via the Y1 receptor.Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis.Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus.Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.Density and pharmacology of alpha5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients.MENINGEAL INFLAMMATION AND CORTICAL DEMYELINATION IN ACUTE MULTIPLE SCLEROSISChanges in [3H]zolpidem and [3H]Ro 15-1788 binding in rat globus pallidus and substantia nigra pars reticulata following a nigrostriatal tract lesionMolecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesisLocalization of sterols and oxysterols in mouse brain reveals distinct spatial cholesterol metabolismCalorie restriction activates new adult born olfactory-bulb neurones in a ghrelin-dependent manner but acyl-ghrelin does not enhance subventricular zone neurogenesisUsing biomarkers to predict clinical outcomes in multiple sclerosis
P50
Q28594443-D9DCE374-A506-41AB-A346-82490B7C3453Q33722349-2FD1364C-5F57-416E-969F-9B658BCAEAC3Q33902217-910F8322-CC3D-4A2E-8833-123ACD318FD1Q34171364-AE0A0E97-D9BB-4F9A-A4B4-78F84FD03360Q34295012-0FC7630F-6DA3-42CD-887F-8BE3B161089FQ34449329-A9DFC345-8917-48E7-841B-BD18961277BBQ35103843-050DBDFF-582F-4D54-9A7A-487F7BAEA1A2Q37031176-338D0BAE-A71F-4247-A76B-080829035D78Q37333728-386D42F9-1581-4307-AE4A-C0D910A62372Q40134939-833AEEB4-374C-44A7-BAA2-5EA1A1D5620BQ42508680-89C9A8D4-705F-4151-9B5C-B94A45B33D47Q42513837-39046920-9D1B-45CF-8B22-4E682C3A2F6CQ42847184-7A37BBA9-EAEC-4F1C-97EA-527944978C9FQ43241664-7F0F24DD-D504-4343-876A-F77450316550Q45373480-CE8487B3-0F4B-493F-85B9-B924874E46E5Q45799560-585E4B07-78F7-4D19-A444-EE6D849FD4D2Q48200750-DBA70D54-8B15-4BF1-8B6C-5808145375E4Q48278633-42D7C8C6-A986-434C-8C43-08C98E0915EFQ48319808-8CECF381-D686-40A1-8040-5F24EC119B9AQ48397010-8401164D-7FAC-45CC-8739-FB360D0F0455Q48925056-6C070AEE-68D8-4942-B280-B1C7E931039DQ48949792-71642D86-80FA-434F-A3BE-29AF8BC10F5BQ50109443-56ED6844-442F-4D6F-A9C8-F93D4AE7B617Q52727867-76D1A3DE-AE05-4A67-B907-9CAAEAC4A237Q53236378-3FB0B2D8-DDC7-44C9-96F0-484223E95107Q58552252-049F97CF-C1B9-4757-BE2E-F125A9378905Q73755368-6C330D7F-8ED6-4473-9A45-26B2D14F5CF0Q88215821-0B610A9C-A148-4967-A0BD-D4491E9EEE34Q90051394-D184DA8E-DC1C-424A-96D6-6C6E62E8A0B0Q92622303-06E4895E-C28F-4208-8269-8DCAB1F08AF1Q93051979-C4815BD8-3001-418B-9B29-3A0773144D1B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Owain W Howell
@es
Owain W. Howell
@en
Owain W. Howell
@nl
Owain W. Howell
@sl
type
label
Owain W Howell
@es
Owain W. Howell
@en
Owain W. Howell
@nl
Owain W. Howell
@sl
altLabel
Owain Howell
@en
prefLabel
Owain W Howell
@es
Owain W. Howell
@en
Owain W. Howell
@nl
Owain W. Howell
@sl
P106
P1153
6602393502
P1960
_39t8d8AAAAJ
P2038
Owain_Howell
P21
P31
P496
0000-0003-2157-9157
P569
2000-01-01T00:00:00Z